NCT05205200ClinicalTrials.gov ↗
This study is a prospective, open-label, phase II clinical study for patients with HR+/HER2- advanced breast cancer.
SHR-1316
3 clinical trials involving this therapy/drug
This is not medical advice - consult your oncologist
Descriptions are automatically translated with AI assistance. Always verify details in the original on ClinicalTrials.gov and consult your treating physician.
RecruitingPhase IIFemale onlyBreast cancerTriple negative (TNBC)HER2 positiveHormone receptor positive (HR+)Early / localized
NCT05582499ClinicalTrials.gov ↗
The purpose of this study is to establish a prospective, single-center platform research based on clinical subtypes to explore precision neoadjuvant therapy in patients with operable breast cancer who met the indications for neoadjuvant chemotherapy and by the update of basic translational research in the center, especially the refinement of typing, the discovery of new targets and the development of novel targeted drugs, verified the effectiveness of new targeted drugs in neoadjuvant therapy.
NCT05076682ClinicalTrials.gov ↗
Badanie testuje połączenie kilku leków wraz z immunoterapią u pacjentów z rakiem piersi, u których poprzednia immunoterapia nie zadziałała. Celem jest sprawdzenie, czy to połączenie jest bezpieczne i skuteczne.
You can help another person
We fund the Radar, this site, and the development of our Grosz dla Życia fundraising platform from donations and our own resources. Every contribution, even a small one, really helps.